✦ LIBER ✦

Prostatic-specif IC antigen: Clinical experience utilizing lmmunoperoxidase staining techniques in patients with metastatic prostate cancer

✍ Scribed by William C. Baker; Frederick J. Meyers; Ralph W. Devere White

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 271 KB
Volume: 37
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930370306

No coin nor oath required. For personal study only.

✦ Synopsis

A human prostatic-specific antigen was first purified in 1979 by M.C. Wang et al. In the years to follow, investigators have been able to develop antisera to prostatic-specific antigen. Using an immunoperoxidase technique to stain both fresh and archival specimens, tissue of prostatic origin can be identified. The stain in our experience has been both specific and sensitive as an indicator of extraprostatic spread of carcinoma. We describe five cases where this technique has been useful in clinical practice.

📜 SIMILAR VOLUMES

Time to prostate-specific antigen nadir

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

✍ Toni K. Choueiri; Wanling Xie; Anthony V. D'Amico; Robert W. Ross; Jim C. Hu; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

Conformal technique dose escalation for

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

✍ Gerald E. Hanks; W.Robert Lee; Alexandra L. Hanlon; Margie Hunt; Edward Kaplan; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 704 KB